These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 30791230)

  • 1. Mass Balance Model with Donnan Equilibrium Accurately Describes Unusual pH and Excipient Profiles during Diafiltration of Monoclonal Antibodies.
    Baek Y; Singh N; Arunkumar A; Borwankar A; Zydney AL
    Biotechnol J; 2019 Jul; 14(7):e1800517. PubMed ID: 30791230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mechanistic model to account for the Donnan and volume exclusion effects in ultrafiltration/diafiltration process of protein formulations.
    Yu Z; Moomaw JF; Thyagarajapuram NR; Geng SB; Bent CJ; Tang Y
    Biotechnol Prog; 2021 Mar; 37(2):e3106. PubMed ID: 33289341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Small-Scale Process for Predicting Donnan and Volume Exclusion Effects During Ultrafiltration/Diafiltration Process Development.
    Abel J; Kosky A; Ball N; Bacon H; Kaushik R; Kleemann GR
    J Pharm Sci; 2018 May; 107(5):1296-1303. PubMed ID: 29339134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theoretical analysis of excipient concentrations during the final ultrafiltration/diafiltration step of therapeutic antibody.
    Miao F; Velayudhan A; DiBella E; Shervin J; Felo M; Teeters M; Alred P
    Biotechnol Prog; 2009; 25(4):964-72. PubMed ID: 19569193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic model of pH and excipient concentration during ultrafiltration and diafiltration processes of therapeutic antibodies.
    Ladwig JE; Zhu X; Rolandi P; Hart R; Robinson J; Rydholm A
    Biotechnol Prog; 2020 Sep; 36(5):e2993. PubMed ID: 32185869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pH and excipient profiles during formulation of highly concentrated biotherapeutics using bufferless media.
    Jabra MG; Tao Y; Moomaw JF; Yu Z; Hotovec BJ; Geng SB; Zydney AL
    Biotechnol Bioeng; 2020 Nov; 117(11):3390-3399. PubMed ID: 32667708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting diafiltration solution compositions for final ultrafiltration/diafiltration steps of monoclonal antibodies.
    Teeters M; Bezila D; Benner T; Alfonso P; Alred P
    Biotechnol Bioeng; 2011 Jun; 108(6):1338-46. PubMed ID: 21328314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pH variations during diafiltration due to buffer nonidealities.
    Baek Y; Yang D; Singh N; Arunkumar A; Ghose S; Li ZJ; Zydney AL
    Biotechnol Prog; 2017 Nov; 33(6):1555-1560. PubMed ID: 28840650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting Formulation Conditions During Ultrafiltration and Dilution to Drug Substance Using a Donnan Model with Homology-Model Based Protein Charge.
    Kannan A; Chinn M; Izadi S; Maier A; Dvornicky J; Fedesco M; Day E; Ladiwala A; Woys A
    J Pharm Sci; 2023 Mar; 112(3):820-829. PubMed ID: 36336103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Designing scalable ultrafiltration/diafiltration process of monoclonal antibodies via mathematical modeling by coupling mass balances and Poisson-Boltzmann equation.
    Ambrožič R; Arzenšek D; Podgornik A
    Biotechnol Bioeng; 2021 Feb; 118(2):633-646. PubMed ID: 33049074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of protein and solution properties on the Donnan effect during the ultrafiltration of proteins.
    Bolton GR; Boesch AW; Basha J; Lacasse DP; Kelley BD; Acharya H
    Biotechnol Prog; 2011; 27(1):140-52. PubMed ID: 21312362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereospecific interactions between histidine and monoclonal antibodies.
    Baek Y; Emami P; Singh N; Ilott A; Sahin E; Zydney A
    Biotechnol Bioeng; 2019 Oct; 116(10):2632-2639. PubMed ID: 31286487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An alternate diafiltration strategy to mitigate protein precipitation for low solubility proteins.
    Gefroh E; Lutz H
    Biotechnol Prog; 2014; 30(3):646-55. PubMed ID: 24449613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass Balance Model with Donnan Equilibrium Accurately Describes Unusual pH and Excipient Profiles during Diafiltration of Monoclonal Antibodies.
    Baek Y; Singh N; Arunkumar A; Borwankar A; Zydney AL
    Biotechnol J; 2020 Sep; 15(9):e2070093. PubMed ID: 32876400
    [No Abstract]   [Full Text] [Related]  

  • 15. Explainable Machine Learning Models to Predict Gibbs-Donnan Effect During Ultrafiltration and Diafiltration of High-Concentration Monoclonal Antibody Formulations.
    Chen CS; Ujiie S; Tanibata R; Kawase T; Kobayashi S
    Biotechnol J; 2024 Oct; 19(10):e202400212. PubMed ID: 39385541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Histidine and Sucrose on the Biophysical Properties of a Monoclonal Antibody.
    Baek Y; Singh N; Arunkumar A; Zydney AL
    Pharm Res; 2017 Mar; 34(3):629-639. PubMed ID: 28035628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling and simulation of protein elution in linear pH and salt gradients on weak, strong and mixed cation exchange resins applying an extended Donnan ion exchange model.
    Wittkopp F; Peeck L; Hafner M; Frech C
    J Chromatogr A; 2018 Apr; 1545():32-47. PubMed ID: 29525127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific ion and buffer effects on protein-protein interactions of a monoclonal antibody.
    Roberts D; Keeling R; Tracka M; van der Walle CF; Uddin S; Warwicker J; Curtis R
    Mol Pharm; 2015 Jan; 12(1):179-93. PubMed ID: 25389571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Near Infrared Spectroscopy as a PAT tool for monitoring and control of protein and excipient concentration in ultrafiltration of highly concentrated antibody formulations.
    Thakur G; Hebbi V; Rathore AS
    Int J Pharm; 2021 May; 600():120456. PubMed ID: 33711473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Countercurrent staged diafiltration for formulation of high value proteins.
    Nambiar AMK; Li Y; Zydney AL
    Biotechnol Bioeng; 2018 Jan; 115(1):139-144. PubMed ID: 28865125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.